Beta Bionics (BBNX) News Today $16.40 -0.39 (-2.32%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Why Is Beta Bionics Down Today?Toggle Visibility of Why Is Beta Bionics Down Today?Beta Bionics, Inc. (NASDAQ:BBNX) shares rose today, driven by strong Q2 results, upbeat guidance and analyst price-target increases, while offsetting a modest cut to near-term earnings estimates. Positive Sentiment: Beta Bionics reported record growth during its Q2 2025 earnings call, highlighting accelerating adoption of its bionic pancreas system. Beta Bionics Reports Record Growth in Earnings Call Positive Sentiment: The company posted strong Q2 financial results and raised its full-year 2025 guidance, reflecting confidence in revenue momentum. Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance Positive Sentiment: Q2 revenue jumped 54% year-over-year, underscoring robust top-line growth in its core diabetes management product line. Beta Bionics (BBNX) Q2 Revenue Soars 54% Positive Sentiment: The stock saw unusually high trading volume following the earnings beat, indicating strong investor interest. Beta Bionics (NASDAQ:BBNX) Sees Unusually-High Trading Volume Following Earnings Beat Positive Sentiment: Shares experienced a large volume increase after better-than-expected Q2 results, reflecting bullish sentiment. Beta Bionics (NASDAQ:BBNX) Sees Large Volume Increase After Better-Than-Expected Earnings Positive Sentiment: Truist Financial raised its price target on BBNX to $21.00 and maintained a “buy” rating, signaling confidence in the company’s growth trajectory. Truist Financial Increases Beta Bionics (NASDAQ:BBNX) Price Target to $21.00 Neutral Sentiment: Robert W. Baird lifted its price target to $17.00 but kept a “neutral” rating, reflecting a cautious outlook on valuation. Beta Bionics (NASDAQ:BBNX) Stock Price Expected to Rise, Robert W. Baird Analyst Says Neutral Sentiment: The full Q2 2025 earnings call transcript was published, offering detailed commentary but no new financial metrics. Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call Transcript Neutral Sentiment: Investors received the Q2 earnings call presentation slides, which detail operational progress but did not alter consensus forecasts. Beta Bionics, Inc. 2025 Q2 - Results - Earnings Call Presentation Negative Sentiment: Leerink Partnrs trimmed its Q3 2025 EPS estimate for BBNX to ($0.43) from ($0.42), suggesting a slightly weaker near-term profit outlook. Leerink Partnrs Cuts Q3 EPS Estimate Posted 14h agoAI Generated. May Contain Errors. BBNX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q3 EPS Estimates for Beta Bionics Lowered by Leerink Partnrs5 hours ago | marketbeat.comBeta Bionics (NASDAQ:BBNX) Price Target Raised to $21.00August 2 at 2:54 AM | americanbankingnews.comBeta Bionics Reports Record Growth in Earnings CallAugust 1 at 3:38 AM | msn.comTruist Financial Increases Beta Bionics (NASDAQ:BBNX) Price Target to $21.00July 31 at 11:56 AM | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Expected to Rise, Robert W. Baird Analyst SaysJuly 31 at 10:41 AM | marketbeat.comBeta Bionics (NASDAQ:BBNX) Sees Large Volume Increase After Better-Than-Expected EarningsJuly 31 at 10:36 AM | marketbeat.comBeta Bionics, Inc. (BBNX) Q2 2025 Earnings Call TranscriptJuly 31 at 10:07 AM | seekingalpha.comBeta Bionics, Inc. 2025 Q2 - Results - Earnings Call PresentationJuly 31 at 9:26 AM | seekingalpha.comBeta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceJuly 31 at 3:09 AM | finanznachrichten.deBeta Bionics (BBNX) Q2 Revenue Soars 54%July 31 at 3:09 AM | theglobeandmail.comBeta Bionics (NASDAQ:BBNX) Sees Unusually-High Trading Volume Following Earnings BeatJuly 31 at 2:29 AM | americanbankingnews.comBeta Bionics (NASDAQ:BBNX) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPSJuly 30 at 4:54 PM | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 5.9% - Here's What HappenedJuly 29, 2025 | marketbeat.comBeta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceJuly 29, 2025 | globenewswire.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives $23.44 Consensus Price Target from AnalystsJuly 27, 2025 | americanbankingnews.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from AnalystsJuly 24, 2025 | marketbeat.comBeta Bionics, Inc.'s (NASDAQ:BBNX) Lock-Up Period To Expire on July 29thJuly 24, 2025 | americanbankingnews.comJennison Associates LLC Purchases New Position in Beta Bionics, Inc. (NASDAQ:BBNX)July 22, 2025 | marketbeat.comBeta Bionics, Inc.'s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX)July 22, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Up 6.5% - Should You Buy?July 19, 2025 | marketbeat.comValues First Advisors Inc. Takes $457,000 Position in Beta Bionics, Inc. (NASDAQ:BBNX)July 8, 2025 | marketbeat.comBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - MorningstarJuly 4, 2025 | morningstar.comMBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - Seeking AlphaJuly 4, 2025 | seekingalpha.comAbbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic PancreasJuly 4, 2025 | msn.comBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025July 2, 2025 | globenewswire.comBeta Bionics, Inc. (BBNX) Income Statement - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 7.7% - Time to Sell?July 1, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by AnalystsJune 29, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 6.8% - Time to Sell?June 23, 2025 | marketbeat.comEvanson Asset Management LLC Takes $475,000 Position in Beta Bionics, Inc. (NASDAQ:BBNX)June 20, 2025 | marketbeat.comBeta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone SensorJune 19, 2025 | globenewswire.comBeta Bionics stock initiated with Buy rating at Truist SecuritiesJune 17, 2025 | investing.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 5.4% - Here's What HappenedJune 17, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Now Covered by Truist FinancialJune 16, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Up 4.7% - What's Next?June 12, 2025 | marketbeat.comLake Street Capital Begins Coverage on Beta Bionics (NASDAQ:BBNX)June 12, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Gap Up - Should You Buy?June 11, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Trading Down 4.8% - Time to Sell?June 6, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Insider Mark Hopman Sells 868 SharesJune 5, 2025 | marketbeat.comSteven Jon Russell Sells 1,039 Shares of Beta Bionics, Inc. (NASDAQ:BBNX) StockJune 5, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Insider Sells $19,947.35 in StockJune 5, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) CFO Sells $26,781.33 in StockJune 5, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Insider Mark Hopman Sells 868 SharesJune 5, 2025 | insidertrades.comBeta Bionics (NASDAQ:BBNX) Shares Gap Up - Here's WhyJune 4, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 4, 2025 | marketbeat.comBeta Bionics Earnings Estimates, EPS & Revenue | NASDAQ:BBNX | BenzingaJune 3, 2025 | benzinga.comWolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform RatingJune 1, 2025 | insidermonkey.comWolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform RatingJune 1, 2025 | msn.comBeta Bionics (NASDAQ:BBNX) Coverage Initiated at The Goldman Sachs GroupMay 31, 2025 | marketbeat.comWolfe Research Initiates Coverage on Beta Bionics (NASDAQ:BBNX)May 31, 2025 | marketbeat.com Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address BBNX Media Mentions By Week BBNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBNX News Sentiment▼0.380.52▲Average Medical News Sentiment BBNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBNX Articles This Week▼214▲BBNX Articles Average Week Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Warby Parker News Today LivaNova News Today National Vision News Today LeMaitre Vascular News Today NovoCure News Today Enovis News Today CONMED News Today Liquidia Technologies News Today Cadre News Today Artivion News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBNX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBNX Stock Alerts